These final results, together with a former report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 assist the principle of targeting ACKR3 as a novel way to modulate the opioid technique, which could open new therapeutic avenues for opioid-similar Issues. Disclaimer: The above mentioned is https://andyp517iaq3.gynoblog.com/profile